Perfluoroalkyl substances and kidney function in chronic kidney disease, anemia, and diabetes

BN Conway, AN Badders, T Costacou… - … syndrome and obesity …, 2018 - Taylor & Francis
Background Anemia often complicates chronic kidney disease (CKD), leading to insufficient
tissue oxygenation and hypoxic injury, the factor thought to underlie progression from CKD …
被引用次数：49 相关文章
[HTML] nih.gov

[HTML][HTML] Perfluoroalkyl substances and kidney function in chronic kidney disease, anemia, and diabetes

BN Conway, AN Badders, T Costacou… - … and Obesity: Targets …, 2018 - ncbi.nlm.nih.gov
Background Anemia often complicates chronic kidney disease (CKD), leading to insufficient
tissue oxygenation and hypoxic injury, the factor thought to underlie progression from CKD …

Perfluoroalkyl substances and kidney function in chronic kidney disease, anemia, and diabetes

BN Conway, AN Badders, T Costacou, JM Arthur… - 2018 - researchrepository.wvu.edu
Background: Anemia often complicates chronic kidney disease (CKD), leading to insufficient
tissue oxygenation and hypoxic injury, the factor thought to underlie progression from CKD …

Perfluoroalkyl substances and kidney function in chronic kidney disease, anemia, and diabetes

BN Conway, AN Badders, T Costacou… - … Syndrome and Obesity …, 2018 - go.gale.com
Background: Anemia often complicates chronic kidney disease (CKD), leading to insufficient
tissue oxygenation and hypoxic injury, the factor thought to underlie progression from CKD …

Perfluoroalkyl substances and kidney function in chronic kidney disease, anemia, and diabetes.

BN Conway, AN Badders, T Costacou… - … and Obesity: Targets …, 2018 - europepmc.org
Background Anemia often complicates chronic kidney disease (CKD), leading to insufficient
tissue oxygenation and hypoxic injury, the factor thought to underlie progression from CKD …

Perfluoroalkyl substances and kidney function in chronic kidney disease, anemia, and diabetes

BN Conway, AN Badders, T Costacou… - Diabetes, Metabolic …, 2018 - dovepress.com
Background: Anemia often complicates chronic kidney disease (CKD), leading to insufficient
tissue oxygenation and hypoxic injury, the factor thought to underlie progression from CKD …

Perfluoroalkyl substances and kidney function in chronic kidney disease, anemia, and diabetes

BN Conway, AN Badders, T Costacou… - … Syndrome and Obesity, 2018 - hero.epa.gov
Background: Anemia often complicates chronic kidney disease (CKD), leading to insufficient
tissue oxygenation and hypoxic injury, the factor thought to underlie progression from CKD …

Perfluoroalkyl substances and kidney function in chronic kidney disease, anemia, and diabetes

BN Conway, AN Badders, T Costacou… - Diabetes, Metabolic …, 2018 - search.proquest.com
Background: Anemia often complicates chronic kidney disease (CKD), leading to insufficient
tissue oxygenation and hypoxic injury, the factor thought to underlie progression from CKD …

Perfluoroalkyl substances and kidney function in chronic kidney disease, anemia, and diabetes

BN Conway, AN Badders… - … targets and therapy, 2018 - pubmed.ncbi.nlm.nih.gov
Background Anemia often complicates chronic kidney disease (CKD), leading to insufficient
tissue oxygenation and hypoxic injury, the factor thought to underlie progression from CKD …

[引用][C] Perfluoroalkyl substances and kidney function in chronic kidney disease, anemia, and diabetes

B Conway, A Badders, T Costacou, J Arthur… - … Syndrome and Obesity …, 2018 - cir.nii.ac.jp
Perfluoroalkyl substances and kidney function in chronic kidney disease, anemia, and diabetes
| CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 論文・データをさがす 大学 …